Literature DB >> 21814134

Potential serotonin 5-HT(1A) and dopamine D(4) receptor modulation of the discriminative stimulus effects of amphetamine in rats.

Danuta Marona-Lewicka1, David E Nichols.   

Abstract

Activation of the dopaminergic system underlies the behavioral effects of (+)-amphetamine, and plays a major role in its discriminative stimulus properties. Although serotonin receptors modulate dopamine levels in the brain, and 5-HT(1A) and 5-HT(2) receptor agonists do not mimic (+)-amphetamine, pretreatment with 5-HT(2A/2C) agonists significantly potentiates the (+)-amphetamine cue. Further, 5-HT(2) antagonists do not modify the discriminative stimulus effect of (+)-amphetamine, but 5-HT(1A) antagonists have never been tested in (+)-amphetamine-trained rats. This study sought to characterize the effects of the 5-HT(1A) antagonist WAY 100635 on (+)-amphetamine-induced discriminative stimulus effects. Male Sprague-Dawley rats were trained in a two-lever, fixed ratio 50, food-reinforced task with (+)-amphetamine sulfate (1.0 mg/kg, i.p., 30 min pretreatment time) as the discriminative stimulus. Substitution and combination tests with WAY 100635 were then performed. WAY 100635 did not produce substitution in amphetamine-trained rats, but significantly increased behavioral disruption. In combination tests 0.4 and 5.4 mg/kg doses of WAY 100635 potentiated the amphetamine cue. We suggest that low doses of WAY 100635 potentiated the (+)-amphetamine cue by blockade of 5-HT(1A) receptors, but stimulation of the dopamine D(4) receptor by higher doses of WAY 100635 may be responsible for potentiation of amphetamine-induced behavioral sensitization. The high percentage of behavioral disruption in substitution tests might suggest that rats trained to discriminate (+)-amphetamine from saline show behavioral sensitization that is not detectable by the drug discrimination assay but may be expressed as hyperactivity and stereotypic behavior that disrupts operant behavior.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21814134      PMCID: PMC3155632          DOI: 10.1097/FBP.0b013e328349fc31

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  51 in total

1.  Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action.

Authors:  Danuta Marona-Lewicka; David E Nichols
Journal:  Pharmacol Biochem Behav       Date:  2007-06-14       Impact factor: 3.533

2.  Drug discrimination training during chronic drug treatment affects the development of tolerance.

Authors:  W F Caul; K L Burgin; R J Barrett
Journal:  Behav Neurosci       Date:  1989-04       Impact factor: 1.912

3.  Selective activation of 5HT1A receptors induces lower lip retraction in the rat.

Authors:  H H Berendsen; F Jenck; C L Broekkamp
Journal:  Pharmacol Biochem Behav       Date:  1989-08       Impact factor: 3.533

4.  The 5-HT1A antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain.

Authors:  L Romero; I Hervás; F Artigas
Journal:  Neurosci Lett       Date:  1996-11-22       Impact factor: 3.046

5.  5-HT2A/2C receptor agonists potentiate the discriminative cue of (+)-amphetamine in the rat.

Authors:  D Marona-Lewicka; D E Nichols
Journal:  Neuropharmacology       Date:  1997-10       Impact factor: 5.250

Review 6.  Monoamine transporters and psychostimulant addiction.

Authors:  Leonard L Howell; Heather L Kimmel
Journal:  Biochem Pharmacol       Date:  2007-08-07       Impact factor: 5.858

7.  An antihyperkinetic action by the serotonin 1A-receptor agonist osemozotan co-administered with psychostimulants or the non-stimulant atomoxetine in mice.

Authors:  Rie Tsuchida; Masahiro Kubo; Mariko Kuroda; Yasuhiro Shibasaki; Norihito Shintani; Michikazu Abe; Katalin Köves; Hitoshi Hashimoto; Akemichi Baba
Journal:  J Pharmacol Sci       Date:  2009-03-07       Impact factor: 3.337

8.  Sensitization to systemic amphetamine produces an enhanced locomotor response to a subsequent intra-accumbens amphetamine challenge in rats.

Authors:  P E Paulson; T E Robinson
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

9.  Discriminative stimulus properties of the 5-HT1A receptor agonist BAY x 3702 in the rat.

Authors:  J De Vry; K R Jentzsch
Journal:  Eur J Pharmacol       Date:  1998-09-11       Impact factor: 4.432

10.  The role of dopamine D4 receptor in the induction of behavioral sensitization to amphetamine and accompanying biochemical and molecular adaptations.

Authors:  D L Feldpausch; L M Needham; M P Stone; J S Althaus; B K Yamamoto; K A Svensson; K M Merchant
Journal:  J Pharmacol Exp Ther       Date:  1998-07       Impact factor: 4.030

View more
  3 in total

1.  Independent of 5-HT1A receptors, neurons in the paraventricular hypothalamus mediate ACTH responses from MDMA.

Authors:  Dmitry V Zaretsky; Maria V Zaretskaia; Joseph A Dimicco; Pamela J Durant; Christian T Ross; Daniel E Rusyniak
Journal:  Neurosci Lett       Date:  2013-08-08       Impact factor: 3.046

Review 2.  Recent advances in multitarget-directed ligands targeting G-protein-coupled receptors.

Authors:  Hongguang Ma; Boshi Huang; Yan Zhang
Journal:  Drug Discov Today       Date:  2020-07-09       Impact factor: 7.851

Review 3.  Psychedelics.

Authors:  David E Nichols
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.